Ocular Hypertension and Glaucoma After Pars Plana Vitrectomy: A Systematic Review and Meta-analysis.

IF 9.5 1区 医学 Q1 OPHTHALMOLOGY
Gabriele Gallo Afflitto, Lorenzo Fabozzi, Filomena Palmieri, Marco Anastasi, Nayana Pant, Orkun Kaymaz, Pier Luigi Surico, Vincenzo Maurino, Francesco Aiello, Carlo Nucci
{"title":"Ocular Hypertension and Glaucoma After Pars Plana Vitrectomy: A Systematic Review and Meta-analysis.","authors":"Gabriele Gallo Afflitto, Lorenzo Fabozzi, Filomena Palmieri, Marco Anastasi, Nayana Pant, Orkun Kaymaz, Pier Luigi Surico, Vincenzo Maurino, Francesco Aiello, Carlo Nucci","doi":"10.1016/j.ophtha.2025.09.027","DOIUrl":null,"url":null,"abstract":"<p><strong>Topic: </strong>To evaluate whether pars plana vitrectomy (PPV) increases the risk of ocular hypertension (OHT) and glaucoma, with particular focus on lens status as a risk modifier.</p><p><strong>Clinical relevance: </strong>OHT and glaucoma are major complications that can threaten vision and require lifelong management. While PPV is a standard treatment for vitreoretinal disease, concerns exist about its long-term effects on intraocular pressure (IOP) and glaucoma, particularly in pseudophakic eyes, where the natural lens barrier is absent. No clear, quantitative synthesis currently informs risk stratification in this context.</p><p><strong>Methods: </strong>The protocol for this systematic review and meta-analysis was prospectively registered in PROSPERO (CRD42024541683), and data reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Eligible studies were randomized or nonrandomized comparative studies reporting OHT or glaucoma after PPV in adults. We last searched Ovid MEDLINE, Ovid EMBASE, and Web of Science on 25 May 2024. Two reviewers independently conducted screening, data extraction, and ROBINS-I risk of bias assessment. Meta-analyses were performed using generalized linear mixed-effects models. Publication bias and heterogeneity were assessed. The ROBINS-I tool was used to assess the risk of bias in nonrandomized studies, and the certainty of evidence was evaluated using GRADE. Numbers needed to treat for harm (NNTH) were calculated using standard formulas as recommended in the Cochrane Handbook to enhance the clinical interpretability of the results.</p><p><strong>Results: </strong>Forty-one observational studies (54,006 eyes) were included. The pooled absolute risk for post-PPV OHT was 5.6% (95%CI: 3.1-9.9; I<sup>2</sup> = 94.6%; low-certainty), and for glaucoma, 3.9% (95% CI, 2.0-7.2; I<sup>2</sup> = 94.4%; low-certainty). Pseudophakic eyes had threefold higher odds of OHT compared to phakic eyes (OR, 3.2; 95%CI: 1.0-9.9; I<sup>2</sup> = 75.1%; NNTH, 8; very low-certainty) and nearly twelvefold higher odds of glaucoma (OR, 11.81; 95%CI: 4.2-33.6; I<sup>2</sup> = 0%; NNTH, 10; moderate-certainty).</p><p><strong>Conclusions: </strong>PPV is associated with clinically meaningful risk of OHT and glaucoma, especially in pseudophakic eyes. Despite limitations from nonrandomized data and heterogeneity, these findings highlight lens status as a key modifier of post-PPV risk and support tailored surgical planning and postoperative monitoring.</p>","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":9.5000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ophtha.2025.09.027","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Topic: To evaluate whether pars plana vitrectomy (PPV) increases the risk of ocular hypertension (OHT) and glaucoma, with particular focus on lens status as a risk modifier.

Clinical relevance: OHT and glaucoma are major complications that can threaten vision and require lifelong management. While PPV is a standard treatment for vitreoretinal disease, concerns exist about its long-term effects on intraocular pressure (IOP) and glaucoma, particularly in pseudophakic eyes, where the natural lens barrier is absent. No clear, quantitative synthesis currently informs risk stratification in this context.

Methods: The protocol for this systematic review and meta-analysis was prospectively registered in PROSPERO (CRD42024541683), and data reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Eligible studies were randomized or nonrandomized comparative studies reporting OHT or glaucoma after PPV in adults. We last searched Ovid MEDLINE, Ovid EMBASE, and Web of Science on 25 May 2024. Two reviewers independently conducted screening, data extraction, and ROBINS-I risk of bias assessment. Meta-analyses were performed using generalized linear mixed-effects models. Publication bias and heterogeneity were assessed. The ROBINS-I tool was used to assess the risk of bias in nonrandomized studies, and the certainty of evidence was evaluated using GRADE. Numbers needed to treat for harm (NNTH) were calculated using standard formulas as recommended in the Cochrane Handbook to enhance the clinical interpretability of the results.

Results: Forty-one observational studies (54,006 eyes) were included. The pooled absolute risk for post-PPV OHT was 5.6% (95%CI: 3.1-9.9; I2 = 94.6%; low-certainty), and for glaucoma, 3.9% (95% CI, 2.0-7.2; I2 = 94.4%; low-certainty). Pseudophakic eyes had threefold higher odds of OHT compared to phakic eyes (OR, 3.2; 95%CI: 1.0-9.9; I2 = 75.1%; NNTH, 8; very low-certainty) and nearly twelvefold higher odds of glaucoma (OR, 11.81; 95%CI: 4.2-33.6; I2 = 0%; NNTH, 10; moderate-certainty).

Conclusions: PPV is associated with clinically meaningful risk of OHT and glaucoma, especially in pseudophakic eyes. Despite limitations from nonrandomized data and heterogeneity, these findings highlight lens status as a key modifier of post-PPV risk and support tailored surgical planning and postoperative monitoring.

玻璃体切除术后高眼压和青光眼:系统回顾和荟萃分析。
主题:评估睫状体切除术(PPV)是否会增加高眼压(OHT)和青光眼的风险,特别关注晶状体状态作为风险调节剂。临床相关性:OHT和青光眼是威胁视力的主要并发症,需要终生治疗。虽然PPV是玻璃体视网膜疾病的标准治疗方法,但人们担心其对眼压(IOP)和青光眼的长期影响,特别是在缺乏天然晶状体屏障的假晶状眼中。目前在这方面还没有明确的定量综合来说明风险分层。方法:本系统评价和荟萃分析的方案在PROSPERO (CRD42024541683)中前瞻性注册,数据报告遵循系统评价和荟萃分析指南的首选报告项目。符合条件的研究是报告成人PPV后OHT或青光眼的随机或非随机比较研究。我们最后一次检索Ovid MEDLINE, Ovid EMBASE和Web of Science是在2024年5月25日。两名审稿人独立进行筛选、数据提取和ROBINS-I偏倚风险评估。采用广义线性混合效应模型进行meta分析。评估发表偏倚和异质性。使用ROBINS-I工具评估非随机研究的偏倚风险,并使用GRADE评估证据的确定性。为了提高结果的临床可解释性,使用Cochrane手册中推荐的标准公式计算治疗伤害所需的数值(NNTH)。结果:纳入41项观察性研究(54,006只眼)。ppv术后OHT的合并绝对风险为5.6% (95%CI: 3.1-9.9; I2 = 94.6%;低确定性),青光眼的合并绝对风险为3.9% (95%CI, 2.0-7.2; I2 = 94.4%;低确定性)。假晶状眼发生OHT的几率是晶状眼的3倍(OR, 3.2; 95%CI: 1.0-9.9; I2 = 75.1%; NNTH, 8;非常低确定性),青光眼的几率是晶状眼的近12倍(OR, 11.81; 95%CI: 4.2-33.6; I2 = 0%; NNTH, 10;中等确定性)。结论:PPV与OHT和青光眼的临床意义相关,尤其是在假性晶状眼中。尽管非随机数据和异质性存在局限性,但这些发现强调晶状体状态是ppv后风险的关键调节因素,并支持量身定制的手术计划和术后监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ophthalmology
Ophthalmology 医学-眼科学
CiteScore
22.30
自引率
3.60%
发文量
412
审稿时长
18 days
期刊介绍: The journal Ophthalmology, from the American Academy of Ophthalmology, contributes to society by publishing research in clinical and basic science related to vision.It upholds excellence through unbiased peer-review, fostering innovation, promoting discovery, and encouraging lifelong learning.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信